Patent directory · USPTO A61K / A61P
Patents matching “THE REGENTS OF THE UNIVERSITY OF MICHIGAN”
774 pharma patents match "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 774 pharmaceutical patents matching "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11110090
Aminopyrimidines as ALK inhibitors
granted -
US 11110177
ASH1L degraders and methods of treatment therewith
granted -
US 11103622
Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (SNAP)-doped nitric oxide release polymers with enhanced stability
granted -
US 11096997
Scaffolds for cell transplantation
granted -
US 11083788
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 11078257
Recombinant gram negative bacteria and methods of generating and utilizing same
granted -
US 11059796
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
granted -
US 11045448
Piperidines as covalent menin inhibitors
granted -
US 11045556
Devices, compositions and related methods for accelerating and enhancing bone repair
granted -
US 11046703
Small molecule MDM2 protein degraders
granted -
US 11046709
Fused 1,4-diazepines as BET bromodomain inhibitors
granted -
US 11033496
Nanoparticles for delivery of chemopreventive agents
granted -
US 11020470
Virus-like particles
granted -
US 11016009
Method for isolating extracellular vesicles using aqueous two-phase system
granted -
US 11013754
Compositions and methods for treating cancer
granted -
US 11008553
Halogenation of complex organic compounds
granted -
US 11000568
Means and methods for treating copper-related diseases
granted -
US 10987434
Detection and treatment of caries and microcavities with nanoparticles
granted -
US 10975093
Fused 1,4-diazepines as BET protein degraders
granted -
US 10953028
Method of treating heterotopic ossification
granted -
US 10941175
Pyrrolopyrimidine nucleosides and analogs thereof
granted -
US 10940160
Biomarkers for predicting responsiveness to decitabine therapy
granted -
US 10928391
CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease
granted -
US 10918673
Immunoisolation device
granted